| JYSZ2400051 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | License Renew | 2024-09-04 | | Sanofi-Aventis Deutschland GmbH;Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| JYSZ2100509 | 精蛋白人胰岛素注射液 | isophane protamine human insulin | Injection | Biological Products | License Renew | 2021-04-23 | | Lilly France;Lilly Suzhou Pharmaceutical Co Ltd | | | view |
| CXSL2400058 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2024-01-25 | | Jiangsu Hengrui Pharmaceuticals Co Ltd | | | view |
| JYSB2200068 | 人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2022-04-13 | | Bioton SA | | | view |
| CYSB2300089 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(原15) | Supplementary Application | 2023-04-27 | | Zhejiang Hisun Pharmaceutical Co Ltd | | | view |
| CXSS2500026 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2025-02-09 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| CYSB2200229 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2101192 | 赖脯胰岛素注射液 | insulin lispro | Injection | Biological Products | Supplementary Application | 2021-09-26 | | Gan & Lee Pharmaceuticals | | | view |
| JYSB2101107 | 地特胰岛素注射液 | insulin detemir | Injection | Biological Products | Supplementary Application | 2021-08-13 | | Novo Nordisk A/S | | | view |
| CYSB2400321 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-12-11 | | Gan & Lee Pharmaceuticals;Gan&Lee Pharmaceuticals Shandong Co Ltd | | | view |
| CYSB2101283 | 人胰岛素注射液 | human insulin | Injection | Biological Products | Supplementary Application | 2021-12-10 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2400080 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2024-04-08 | | Lilly France;Eli Lilly Nederland BV | | | view |
| CYSB2200161 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2022-06-29 | | Sanofi (Beijing) Pharmaceuticals Co Ltd | | | view |
| CXSS2200079 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | New Drug Application | 2022-09-17 | | Hefei Tianmai BIOTECHNOLOGY Development Co Ltd | | | view |
| CXSL2300433 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2023-06-27 | | Fosun Wanbang (Jiangsu) Pharmaceutical Group Co Ltd | | | view |
| CXSL2500370 | 德谷门冬双胰岛素注射液 | insulin degludec;Insulin Aspart | Injection | Biological Products(3.3) | New Drug Application | 2025-05-10 | | Yifan Pharmaceutical (Shanghai) Co Ltd | | | view |
| CYSB2200127 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products(3.3) | Supplementary Application | 2022-06-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
| JYSZ2300009 | 人胰岛素注射液 | human insulin | Injection | Biological Products | License Renew | 2023-02-14 | | Bioton SA;SciGen (Beijing) Biotechnology Co Ltd | | | view |
| CYSB2200117 | 甘精胰岛素注射液 | insulin glargine | Injection | Biological Products | Supplementary Application | 2022-05-18 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CXSL2200241 | 德谷胰岛素注射液 | insulin degludec | Injection | Biological Products(3.3) | New Drug Application | 2022-06-03 | | Nanjing Sinor Biotechnology Co Ltd;Nanjing Cellnuo Biopharmaceutical Co Ltd | | | view |
